Trial Profile
Comparison of the nighttime effects of rabeprazole 20 mg to pantoprazole 40 mg on standard meal stimulated gastric acid secretion and intragastric pH in H. pylori [helicobacter pylori] negative volunteer subjects with GERD [gastro-oesophageal reflux]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2007
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary) ; Rabeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Pharmacodynamics
- 14 Sep 2007 Status change
- 15 Oct 2006 New trial record.